J0153 HCPCS Level II code: Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)
J0153 is the HCPCS code for “Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)” in CMS’s October 2026 release, in effect from Oct 1, 2026.
Official description
J0153Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)
Short description: Adenosine inj 1mg
HCPCS · United States
Notes for J0153
As CMS prints them, with any note J0153 takes from the headings above it.
Note
- CMS processing note 0194: PUB. 100-4, CH. 15.
Medicare details
The indicators CMS publishes with J0153 in its October 2026 file. They describe Medicare’s handling, not another payer’s.
- Medicare coverage
- Special coverage instructions apply
- Medicare pricing
- Drugs
- Type of service
- Medical care; Lump sum purchase of DME, prosthetics, orthotics
- BETOS category
- Other drugs
- Added
- Jan 1, 2015
Where J0153 sits
- 1J codesDrugs administered other than orally
- 2Active code J0153Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)
Source and release
- Data release
- HCPCS Level II · October 2026
- Effective date
- Oct 1, 2026
- Publisher
- CMS
This page is built from the HCPCS Level II catalog that Vero Codes reads when it suggests codes: Centers for Medicare & Medicaid Services’s October 2026 release, imported from the publisher’s file and checked against it. The description, notes and structured data come from the same record.
Frequently asked questions
What does HCPCS code J0153 mean?
J0153 is the HCPCS code for “Injection, adenosine, 1 mg (not to be used to report any adenosine phosphate compounds)” in CMS’s HCPCS Level II October 2026 release.
Does Medicare cover J0153?
CMS lists J0153’s Medicare coverage as “Special coverage instructions apply” and its pricing as “Drugs”. Coverage and payment still depend on the patient, the setting, the documentation and the payer.
Which HCPCS Level II release does this page use?
It uses CMS’s October 2026 release, in effect from Oct 1, 2026 to Dec 31, 2026. It is a reference: confirm the code against the current list and the payer’s rules before you submit it.
Codes beside J0153
All J codesJ0136Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mgJ0137Injection, acetaminophen (hikma), not therapeutically equivalent to j0131, 10 mgJ0138Injection, acetaminophen 10 mg and ibuprofen 3 mgJ0139Injection, adalimumab, 1 mgJ0150Injection, adenosine for therapeutic use, 6 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)J0151Injection, adenosine for diagnostic use, 1 mg (not to be used to report any adenosine phosphate compounds, instead use a9270)J0162Injection, epinephrine (fresenius), not therapeutically equivalent to j0165, 0.1 mgJ0163Injection, epinephrine in sodium chloride (endo), 0.1 mgJ0164Injection, epinephrine in sodium chloride (baxter), 0.1 mgJ0165Injection, epinephrine, not otherwise specified, 0.1 mgJ0166Injection, epinephrine (bpi), not therapeutically equivalent to j0165, 0.1 mgJ0167Injection, epinephrine (hospira), not therapeutically equivalent to j0165, 0.1 mg